Profound Medical (PROF) Return on Capital Employed (2025 - 2026)
Profound Medical (PROF) recorded quarterly Return on Capital Employed of 4.94% in Q1 2026, up 58.13% quarter-over-quarter from 11.8% in Q4 2025, and up 5539.0% on a YoY basis from 0.09% in Q1 2025.
Profound Medical (PROF) Return on Capital Employed (2025 - 2026) Analysis & Trends
Profound Medical's Return on Capital Employed history runs 2 years deep, the most recent figure standing at 4.94% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 5539.0% year-over-year to 4.94%; the TTM figure through Mar 2026 stood at 4.94% (up 5539.0% YoY), while the FY2025 annual figure was 9.37%, up 5606.0% from the prior year.
- Return on Capital Employed was 4.94% for Q1 2026 at Profound Medical, up from 11.8% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 4.94% in Q1 2026 to a low of 117.15% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 11.13% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 9.30% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 24.24% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 11.57% |
| 10 | Profound Medical | 240.29 Mn | 190.00 Mn | 3.83 Mn | -4.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.94% |
| Dec 31, 2025 | -11.80% |
| Sep 30, 2025 | -117.15% |
| Jun 30, 2025 | -85.41% |
| Mar 31, 2025 | -60.33% |